» Articles » PMID: 3791726

Malignant Melanoma Cell Lines Selected in Vitro for Increased Homotypic Adhesion Properties Have Increased Experimental Metastatic Potential

Overview
Specialty Oncology
Date 1986 Oct 1
PMID 3791726
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Using unselected and selected B16 melanoma cell lines, we examined the relationship between homotypic aggregation properties and the potential to form experimental metastatic lung colonies. The B16 sublines were selected in vitro from a line with relatively low homotypic aggregation kinetics and experimental metastatic potential (B16-F1) by successive steps of cell aggregation, followed by separation of cell aggregates from single cells. The selected sublines possessed significantly higher rates of aggregation than did the parental cell line and, when injected intravenously as single cells, formed greater numbers of lung tumor colonies. The aggregation kinetics of the parental and selected cell lines were dependent on divalent cations, with the following order of selectivity: Ca2+ greater than Mn2+ much greater than Mg2+. Syngeneic and xenogeneic serum components and the protease inhibitor leupeptin enhanced the aggregation kinetics of various B16 cell lines. The results support the proposal that a positive correlation exists between increased homotypic adhesion and experimental metastatic potential.

Citing Articles

An agarose-alginate microfluidic device for the study of spheroid invasion, ATRA inhibits CAFs-mediated matrix remodeling.

Nasiraee M, Shahrivari S, Sayad S, Mahdavi H, Saraygord-Afshari N, Bagheri Z Cytotechnology. 2023; 75(4):309-323.

PMID: 37389131 PMC: 10299977. DOI: 10.1007/s10616-023-00578-y.


Quantitative Analysis of Cell Aggregation Dynamics Identifies HDAC Inhibitors as Potential Regulators of Cancer Cell Clustering.

Gava F, Pignolet J, Dejean S, Mondesert O, Morin R, Agossa J Cancers (Basel). 2021; 13(22).

PMID: 34830995 PMC: 8616495. DOI: 10.3390/cancers13225840.


Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs).

Mathias T, Chang K, Martin S, Vitolo M Cancers (Basel). 2020; 12(3).

PMID: 32245166 PMC: 7140032. DOI: 10.3390/cancers12030743.


Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential.

Allen T, Asad D, Amu E, Hensley M, Cores J, Vandergriff A J Cell Sci. 2019; 132(17).

PMID: 31409692 PMC: 6771143. DOI: 10.1242/jcs.231563.


Defining the Hallmarks of Metastasis.

Welch D, Hurst D Cancer Res. 2019; 79(12):3011-3027.

PMID: 31053634 PMC: 6571042. DOI: 10.1158/0008-5472.CAN-19-0458.


References
1.
Nicolson G . Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta. 1982; 695(2):113-76. DOI: 10.1016/0304-419x(82)90020-8. View

2.
Urushihara H, Ikawa Y, Tsuruo T . Adhesive properties of weakly and highly metastatic melanoma cell lines. Gan. 1984; 75(6):534-9. View

3.
Honn K, CAVANAUGH P, Evens C, Taylor J, Sloane B . Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin. Science. 1982; 217(4559):540-2. DOI: 10.1126/science.7046053. View

4.
Raz A, Meromsky L, Lotan R . Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells. Cancer Res. 1986; 46(7):3667-72. View

5.
Nicolson G, Winkelhake J . Organ specificity of blood-borne tumour metastasis determined by cell adhesion?. Nature. 1975; 255(5505):230-2. DOI: 10.1038/255230a0. View